{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:26:51Z","timestamp":1769279211454,"version":"3.49.0"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1248\/bpb.b18-00316","type":"journal-article","created":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T22:10:21Z","timestamp":1538345421000},"page":"1615-1619","source":"Crossref","is-referenced-by-count":4,"title":["A Flow Cytometry-Based Method to Determine the Titer of Adenoviruses Expressing an Extraneous Gene"],"prefix":"10.1248","volume":"41","author":[{"given":"Akikazu","family":"Asada","sequence":"first","affiliation":[{"name":"Oncolys BioPharma, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Oncolys BioPharma, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Yanase","sequence":"additional","affiliation":[{"name":"Oncolys BioPharma, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Abe","sequence":"additional","affiliation":[{"name":"Oncolys BioPharma, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Urata","sequence":"additional","affiliation":[{"name":"Oncolys BioPharma, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S, Tanaka N, Fujiwara T. Telomerase specific replication-selective virotherapy for human cancer. Clin. Cancer Res.<\/i>, 10<\/b>, 285\u2013292 (2004).","DOI":"10.1158\/1078-0432.CCR-1075-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nemunaitis J, Tong AW, Nemunaitis M, Senzer N, Phadke AP, Bedell C, Adams N, Zhang YA, Maples PB, Chen S, Pappen B, Burke J, Ichimaru D, Urata Y, Fujiwara T. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol. Ther.<\/i>, 18<\/b>, 429\u2013434 (2010).","DOI":"10.1038\/mt.2009.262"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol.<\/i>, 47<\/b>, 157\u2013166 (1994).","DOI":"10.7883\/yoken1952.47.157"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol.<\/i>, 70<\/b>, 7498\u20137509 (1996).","DOI":"10.1128\/JVI.70.11.7498-7509.1996"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hitt DC, Booth JL, Dandapani V, Pennington LR, Gimble JM, Metcalf J. A flow cytometric protocol for titering recombinant adenoviral vectors containing the green fluorescent protein. Mol. Biotechnol.<\/i>, 14<\/b>, 197\u2013203 (2000).","DOI":"10.1385\/MB:14:3:197"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gueret V, Negrete-Virgen JA, Lyddiatt A, Al-Rubeai M. Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells. Cytotechnology<\/i>, 38<\/b>, 87\u201397 (2002).","DOI":"10.1023\/A:1021106116887"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, Fujiwara T, Penman S, Hoffman RM. In vivo<\/i> internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 106<\/b>, 14514\u201314517 (2009).","DOI":"10.1073\/pnas.0906388106"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sakurai F, Narii N, Tomita K, Togo S, Takahashi K, Machitani M, Tachibana M, Ouchi M, Katagiri N, Urata Y, Fujiwara T, Mizuguchi H. Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus. Mol. Ther. Methods Clin. Dev.<\/i>, 3<\/b>, 16001 (2016).","DOI":"10.1038\/mtm.2016.1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sebaugh JL. Guidelines for accurate EC50\/IC50 estimation. Pharm. Stat.<\/i>, 10<\/b>, 128\u2013134 (2011).","DOI":"10.1002\/pst.426"},{"key":"10","unstructured":"10) Maizel JV Jr, White DO, Scharff MD. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology<\/i>, 36<\/b>, 115\u2013125 (1968)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Green M, Pina M. Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology<\/i>, 20<\/b>, 199\u2013207 (1963).","DOI":"10.1016\/0042-6822(63)90157-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Graham FL, Prevec L. Manipulation of adenovirus vectors. Methods Mol. Biol.<\/i>, 7<\/b>, 109\u2013128 (1991).","DOI":"10.1385\/0-89603-178-0:109"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Grabow WO, Puttergill DL, Bosch A. Propagation of adenovirus types 40 and 41 in the PLC\/PRF\/5 primary liver carcinoma cell line. J. Virol. Methods<\/i>, 37<\/b>, 201\u2013207 (1992).","DOI":"10.1016\/0166-0934(92)90047-H"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kishimoto H, Urata Y, Tanaka N, Fujiwara T, Hoffman RM. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol. Cancer Ther.<\/i>, 8<\/b>, 3001\u20133008 (2009).","DOI":"10.1158\/1535-7163.MCT-09-0556"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kishimoto H, Aki R, Urata Y, Bouvet M, Momiyama M, Tanaka N, Fujiwara T, Hoffman RM. Tumor-selective adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle<\/i>, 10<\/b>, 2737\u20132741 (2011).","DOI":"10.4161\/cc.10.16.16756"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yano S, Tazawa H, Hashimoto Y, Shirakawa Y, Kuroda S, Nishizaki M, Kishimoto H, Uno F, Nagasaka T, Urata Y, Kagawa S, Hoffman RM, Fujiwara T. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells into S\/G2\/M phases. Clin. Cancer Res.<\/i>, 19<\/b>, 6495\u20136505 (2013).","DOI":"10.1158\/1078-0432.CCR-13-0742"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yano S, Miwa S, Kishimoto H, Uehara F, Tazawa H, Toneri M, Hiroshima Y, Yamamoto M, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma. Oncotarget<\/i>, 6<\/b>, 13133\u201313148 (2015).","DOI":"10.18632\/oncotarget.3811"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yano S, Miwa S, Kishimoto H, Toneri M, Hiroshima Y, Yamamoto M, Bouvet M, Urata Y, Tazawa H, Kagawa S, Fujiwara T, Hoffman RM. Experimental curative fluorescence-guided surgery of highly invasive glioblastoma multiforme selectively labeled with a killer-reporter adenovirus. Mol. Ther.<\/i>, 23<\/b>, 1182\u20131188 (2015).","DOI":"10.1038\/mt.2015.63"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Onishi T, Tazawa H, Hashimoto Y, Takeuchi M, Otani T, Nakamura S, Sakurai F, Mizuguchi H, Kishimoto H, Umeda Y, Shirakawa Y, Urata Y, Kagawa S, Fujiwara T. Tumor-specific delivery of biologics by a novel T-cell line HOZOT. Sci. Rep.<\/i>, 6<\/b>, 38060 (2016).","DOI":"10.1038\/srep38060"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro<\/i>. Cancer Gene Ther.<\/i>, 24<\/b>, 45\u201347 (2017).","DOI":"10.1038\/cgt.2016.67"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Togo S, Katagiri N, Namba Y, Tulafu M, Nagahama K, Kadoya K, Takamochi K, Oh S, Suzuki K, Sakurai F, Mizuguchi H, Urata Y, Takahashi K. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients. Oncotarget<\/i>, 8<\/b>, 34884\u201334895 (2017).","DOI":"10.18632\/oncotarget.16818"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hasei J, Sasaki T, Tazawa H, Osaki S, Yamakawa Y, Kunisada T, Yoshida A, Hashimoto Y, Onishi T, Uno F, Kagawa S, Urata Y, Ozaki T, Fujiwara T. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Mol. Cancer Ther.<\/i>, 12<\/b>, 314\u2013325 (2013).","DOI":"10.1158\/1535-7163.MCT-12-0869"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S, Yoshida R, Uno F, Mizuguchi H, Ohtsuru A, Urata Y, Kagawa S, Fujiwara T. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Eur. J. Cancer<\/i>, 48<\/b>, 2282\u20132291 (2012).","DOI":"10.1016\/j.ejca.2011.12.020"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Tazawa H, Kagawa S, Fujiwara T. Advances in adenovirus-mediated p53 cancer gene therapy. Expert Opin. Biol. Ther.<\/i>, 13<\/b>, 1569\u20131583 (2013).","DOI":"10.1517\/14712598.2013.845662"},{"key":"25","unstructured":"25) Chen GX, Zhang S, He XH, Liu SY, Ma C, Zou XP. Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. Onco. Targets Ther.<\/i>, 7<\/b>, 1901\u20131909 (2014)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Shin S-P, Seo H-H, Shin J-H, Park H-B, Lim D-P, Eom H-S, Bae Y-S, Kim I-H, Choi K, Lee S-J. Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response. Mol. Ther.<\/i>, 21<\/b>, 688\u2013695 (2013).","DOI":"10.1038\/mt.2012.252"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Eriksson E, Milenova I, Wenthe J, St\u00e5hle M, Leja-Jarblad J, Ullenhag G, Dimberg A, Moreno R, Alemany R, Loskog A. Shaping the tumor stroma and sparking immune activation by CD40 and 4-1BB signaling induced by an armed oncolytic virus. Clin. Cancer Res.<\/i>, 23<\/b>, 5846\u20135857 (2017).","DOI":"10.1158\/1078-0432.CCR-17-0285"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, Yuan Y, Lang FF, Toniatti C, Hossain MB, Fueyo J. Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination. Cancer Res.<\/i>, 77<\/b>, 3894\u20133907 (2017).","DOI":"10.1158\/0008-5472.CAN-17-0468"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/10\/41_b18-00316\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T12:23:22Z","timestamp":1605097402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/10\/41_b18-00316\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00316","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}